You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

The Cochrane Library Editorials

Syndicate content
The Cochrane Database of Systematic Reviews (CDSR) is the leading resource for systematic reviews in health care. The CDSR includes Cochrane Reviews (the systematic reviews) and protocols for Cochrane Reviews as well as Editorials.
Updated: 23 min 11 sec ago

Avoiding or stopping steroids in kidney transplant recipients: sounds good but does it work?

30 August 2016 - 12:40pm
Receiving a kidney transplant is transformative for a patient who is on dialysis. Transplantation means a major operation, short-term and long-term monitoring, and multiple drugs to prevent rejection of the new organ, but it also brings the promise of a more normal life. Corticosteroids have been one of the mainstays for preventing rejection since the inception of solid organ transplantation, but reducing the risk of rejection needs to be carefully balanced against the harms of corticosteroids. An updated Cochrane Review provides more information on this important topic.

High dose, high risk? What updated evidence tells us about chemotherapy dosing in early breast cancer

20 May 2016 - 4:36pm
Chemotherapy is established as an effective therapy for early breast cancer, reducing recurrence rates and improving survival. It was postulated that higher doses of treatment might be more effective. An updated Cochrane Review includes data from extended follow-up from existing trials, and we now have high-quality evidence that high-dose chemotherapy does not improve survival in breast cancer.

Comments for improvement or correction are welcome.
Email: web@cochrane.org